ExploreWatchlistsPricing
  1. JP-listed companies
  2. Pharma Foods International Co., Ltd.
  3. Financials
  4. Earnings per share

Pharma Foods International Co., Ltd. (2929)

Market cap
¥19B
P/E ratio
12.6x
Pharmafoods develops functional ingredients and manufactures supplements, cosmetics, and drug treatments for food companies, pharmaceutical firms, and consumers through direct sales.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Jul 31, 202512.8-88.62%
Jul 31, 2024112.7+5.63%
Jul 31, 2023106.7-927.77%
Jul 31, 2022-12.9-109.75%
Jul 31, 2021132.2+455.74%
Jul 31, 202023.8+38.23%
Jul 31, 201917.2+59.35%
Jul 31, 201810.8+209.46%
Jul 31, 20173.5+292.13%
Jul 31, 20160.9-113.71%
Jul 31, 2015-6.5-2008.82%
Jul 31, 20140.3-98.52%
Jul 31, 201322.9+348.53%
Jul 31, 20125.1-100.64%
Jul 31, 2011-793.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat